Biocon informs about press release

29 Dec 2017 Evaluate

Biocon has informed about Press Release titled ‘Biocon and Mylans Biosimilar Trastuzumab Receives Approval from ANVISA, Brazil Through Their Partner Libbs’.

The above information is a part of company’s filings submitted to BSE.

Biocon Share Price

323.15 -3.95 (-1.21%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.65
Dr. Reddys Lab 1194.55
Cipla 1465.65
Lupin 2043.30
Zydus Lifesciences 944.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.